BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17690452)

  • 1. Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats.
    Shimada M; Mochizuki K; Sakurai N; Goda T
    Biosci Biotechnol Biochem; 2007 Aug; 71(8):2079-82. PubMed ID: 17690452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
    Uchiyama Y; Suzuki T; Mochizuki K; Goda T
    J Agric Food Chem; 2013 Nov; 61(47):11410-7. PubMed ID: 24206061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.
    Uchiyama Y; Suzuki T; Mochizuki K; Goda T
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(6):541-7. PubMed ID: 24477251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate attenuated myocardial mitochondrial dysfunction and autophagy in diabetic Goto-Kakizaki rats.
    Liu J; Tang Y; Feng Z; Liu J; Liu J; Long J
    Free Radic Res; 2014 Aug; 48(8):898-906. PubMed ID: 24797301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
    Yan J; Feng Z; Liu J; Shen W; Wang Y; Wertz K; Weber P; Long J; Liu J
    J Nutr Biochem; 2012 Jul; 23(7):716-24. PubMed ID: 21820301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass.
    Wolfram S; Raederstorff D; Wang Y; Teixeira SR; Elste V; Weber P
    Ann Nutr Metab; 2005; 49(1):54-63. PubMed ID: 15735368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate supplementation alleviates diabetes in rodents.
    Wolfram S; Raederstorff D; Preller M; Wang Y; Teixeira SR; Riegger C; Weber P
    J Nutr; 2006 Oct; 136(10):2512-8. PubMed ID: 16988119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rice protein ameliorates the progression of diabetic nephropathy in Goto-Kakizaki rats with high-sucrose feeding.
    Kubota M; Watanabe R; Kabasawa H; Iino N; Saito A; Kumagai T; Fujimura S; Kadowaki M
    Br J Nutr; 2013 Oct; 110(7):1211-9. PubMed ID: 23537514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats.
    Kim DS; Kim TW; Kang JS
    J Trace Elem Med Biol; 2004; 17(4):243-7. PubMed ID: 15139386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in hepatic metabolism of sulfur amino acids in non-obese type-2 diabetic Goto-Kakizaki rats.
    Jung YS; Yun KU; Ryu CS; Oh JM; Kwak HC; Lee JY; Park SK; Kim BH; Oh SJ; Kim SK
    Chem Biol Interact; 2013 Jul; 204(2):80-7. PubMed ID: 23665415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin inhibition on adipokines in diabetic rats.
    Hassanin A; Malek HA
    Pak J Pharm Sci; 2014 Jul; 27(4):767-72. PubMed ID: 25015438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG).
    Oršolić N; Sirovina D; Gajski G; Garaj-Vrhovac V; Jazvinšćak Jembrek M; Kosalec I
    Mutat Res; 2013 Sep; 757(1):36-44. PubMed ID: 23859956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms.
    Roghani M; Baluchnejadmojarad T
    Vascul Pharmacol; 2009; 51(2-3):84-9. PubMed ID: 19393342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
    Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats.
    Yun SY; Kim SP; Song DK
    Eur J Pharmacol; 2006 Jul; 541(1-2):115-21. PubMed ID: 16765345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
    Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
    Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.